PMVP

0.876033.13%
DJ

Deepika Jalota

Chief Development Officer

Dr. Deepika Jalota, Pharm.D., serves as Chief Development Officer at PMV Pharmaceuticals, Inc. since May 2023 and served as its Chief Regulatory and Quality Assurance Officer since February 2021 until May 2023. Dr. Jalota was Senior Vice President of Regulatory Affairs and Quality Assurance at PMV Pharmaceuticals, Inc. since June 13, 2019 until February 2021. Prior to joining PMV Pharma, Dr. Jalota was employed by Bayer HealthCare Pharmaceuticals from July 2007 to May2019 and was Vice President & Global Regulatory Strategy Head of Oncology I from July 2017 to June 2019. Dr. Jalota also served as Senior Director of Global Regulatory Strategy - Oncology from June 2016 to July 2017 and Director and Head of Global Regulatory Strategy of Dermatology and Ophthalmology from January 2014 to June 2016. Prior to joining Bayer, Dr. Jalota was employed with Sanofi-Aventis, Forest Laboratories and Procter and Gamble. Dr. Jalota leads the regulatory efforts for PMV Pharma's mutant p53 restoration drug pipeline drawing upon her experience leading global regulatory strategy for both early and late stage oncology therapeutics. Dr. Jalota received a B.S. in Pharmacy from Rutgers University, Ernest Mario School of Pharmacy and a Pharm.D. from University of Florida, College of Pharmacy.

Positions